
Myllia Biotechnology
@mylliabio
Primary cell CRISPR screens to accelerate drug target discovery and genetic screening for cellular phenotypes at single-cell resolution
ID: 1141339667146653696
http://www.myllia.com 19-06-2019 13:39:16
77 Tweet
92 Takipçi
46 Takip Edilen

This week, Myllia Biotechnology welcomed LukeGilbert from the UC San Francisco and Christoph Bock from the Christoph Bock Lab @ CeMM & MedUni Vienna at CeMM for the annual SAB meeting in Vienna, Austria! The day was focused on Myllia’s technology platform combining CRISPR perturbation with single-cell RNA sequencing.
